2.78
price down icon4.79%   -0.14
after-market Dopo l'orario di chiusura: 2.78
loading

Mustang Bio Inc Borsa (MBIO) Ultime notizie

pulisher
08:39 AM

Mustang Bio sets terms for $8M public offering - MSN

08:39 AM
pulisher
Feb 06, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewswire

Feb 06, 2025
pulisher
Feb 06, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering - Benzinga

Feb 06, 2025
pulisher
Feb 06, 2025

Capital Raise Alert: Mustang Bio Secures Fresh $8M Funding Through Strategic Share & Warrant Offering - StockTitan

Feb 06, 2025
pulisher
Feb 05, 2025

Mustang Bio says it needs additional funds to avoid bankruptcy - The Business Journals

Feb 05, 2025
pulisher
Jan 31, 2025

Mustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary - Benzinga

Jan 31, 2025
pulisher
Jan 31, 2025

Mustang Bio stock plunges to 52-week low of $4 - MSN

Jan 31, 2025
pulisher
Jan 22, 2025

Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025
pulisher
Jan 17, 2025

Stock market today: VerifyMe -14.42%, PTL -13.23% among biggest losers in early trading - Business Upturn

Jan 17, 2025
pulisher
Jan 17, 2025

Mustang Bio Inc. Appoints Michael J. Zelefsky as Director -June 13, 2017 at 04:02 pm EDT - Marketscreener.com

Jan 17, 2025
pulisher
Jan 17, 2025

Mustang Bio, Inc. Announces Management Changes -April 24, 2017 at 08:00 am EDT - Marketscreener.com

Jan 17, 2025
pulisher
Jan 17, 2025

Mustang Bio, Inc. Appoints Peter Carney as the Interim Chief Accounting Officer -December 12, 2023 at 06:23 am EST - Marketscreener.com

Jan 17, 2025
pulisher
Jan 16, 2025

Mustang Bio, Inc. Terminates Exclusive License Agreement with Regents of the University of California - Marketscreener.com

Jan 16, 2025
pulisher
Jan 16, 2025

UBriGene Biosciences Inc. completed the acquisition of Worcester manufacturing facility of Mustang Bio, Inc. - Marketscreener.com

Jan 16, 2025
pulisher
Jan 16, 2025

Mustang Bio, Inc. Announces CFO Changes -November 15, 2024 at 04:50 pm EST - Marketscreener.com

Jan 16, 2025
pulisher
Jan 16, 2025

Mustang Bio stock plunges to 52-week low of $0.13 By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 15, 2025

Mustang Bio stock plunges to 52-week low of $0.13 - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

Mustang Bio Announces Reverse Stock Split - GlobeNewswire

Jan 15, 2025
pulisher
Jan 14, 2025

Mustang Bio announces 1-for-50 reverse stock split By Investing.com - Investing.com Nigeria

Jan 14, 2025
pulisher
Jan 14, 2025

Dow Gains Over 200 Points; Signet Jewelers Shares Plunge - Benzinga

Jan 14, 2025
pulisher
Jan 14, 2025

Mustang Bio Lauds New Stock Split - Baystreet.ca

Jan 14, 2025
pulisher
Jan 14, 2025

Mustang Bio announces 1-for-50 reverse stock split - Investing.com India

Jan 14, 2025
pulisher
Jan 11, 2025

Mustang Bio secures shareholder nod for major stock issuance By Investing.com - Investing.com Nigeria

Jan 11, 2025
pulisher
Jan 11, 2025

Mustang Bio secures shareholder nod for major stock issuance - Investing.com India

Jan 11, 2025
pulisher
Jan 07, 2025

Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off - MSN

Jan 07, 2025
pulisher
Jan 06, 2025

Fortress Biotech subsidiary's drug application accepted by FDA - Investing.com

Jan 06, 2025
pulisher
Jan 03, 2025

Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews

Jan 03, 2025
pulisher
Jan 02, 2025

Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn

Jan 02, 2025
pulisher
Jan 02, 2025

Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data | Stock Market News - Mint

Jan 02, 2025
pulisher
Dec 27, 2024

Mustang Bio files to sell 34.77M shares of common stock for holders - MSN

Dec 27, 2024
pulisher
Dec 25, 2024

Mustang Bio Inc Still Hasn’t Convinced Analysts? - Stocks Register

Dec 25, 2024
pulisher
Dec 17, 2024

Fortress Biotech subsidiary gains FDA approval for cSCC therapy - Investing.com

Dec 17, 2024
pulisher
Dec 04, 2024

Likelihood of Approval and Phase Transition Success Rate ModelMB-108 in Recurrent Malignant Glioma - GlobalData

Dec 04, 2024
pulisher
Nov 29, 2024

Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 29, 2024
pulisher
Nov 17, 2024

Mustang Bio faces delisting, appoints new interim CFO - Investing.com

Nov 17, 2024
pulisher
Nov 15, 2024

Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024
pulisher
Nov 12, 2024

Crude Oil Brent (F) (QAX25) Quote - The Globe and Mail

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Capitalizzazione:     |  Volume (24 ore):